Discover Virbac

28.png

Welcome to M.E.K.C.

THE MIDDLE EAST KENNEL CLUB WAS FOUNDED IN 2005.

The Middle East Kennel Club is operative as of March 2005 to care about pets. To improve the pure-breed dogs was one of his aims with the assistance and expertise of the World Wide Kennel Club.

M.E.K.C is the sole authorized agent for the Worldwide Kennel Club (USA) which makes us stand firm and strong ready to serve with the right quality product and service as well as sole authorized distributors for VIRBAC.

Find out more about The Virbac Group
Virbac Group

Virbac Group

With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.

Founder

Founder

From a small biology research center established in 1968 in a three-room apartment in Nice to the world’s 7th largest laboratory, a look back at the beginnings of great human adventure.

Values

Values

Nurture entrepreneurship, stimulate innovation, demonstrate our engagement, foster a customer-driven approach, pay attention to people and choose sustainability...

History

1968

1970

1970

1973

1977

1982

1982

1985

1987

1988

1989

1991

1992

1992

1996

1998

1999

1999

2001

2001

2001

2006

2006

2008

2008

2010

2011

2012

2015

2015

2016

2017

2017

2017

2018

2018

2018

2018

2019

1968

PRD.pngCreation of the SARL Virbac biological research center.

1970

1970.pngVirbac starts marketing its products internationally, thanks to distribution partnerships in Benelux and Germany.

1970

COLLIER.pngVirbac develops the first insecticide collar for dogs, which would later become one of the Group’s flagship products.

1973

batiment-construction.pngVirbac constructs the first building of its future headquarters in Carros, near Nice, quickly adding a production and storage unit and a loading dock.

1977

rilexine.pngVirbac offers the first cephalosporin in veterinary medicine (for dogs, cats and cattle), in France, thus providing an alternative to the cephalosporins derived from human pharmaceuticals.

1982

parvovirus.pngIn response to the viral gastroenteritis epidemic decimating dog breeding, Virbac creates the first parvovirus-based vaccine approved for dogs, thus entering the very exclusive club of innovative vaccine-developing laboratories.

1982

filiale-allemagne.pngOpening of the first subsidiary in Germany, following acquisition of local distributor VMG, thus marking the beginning of Virbac’s deployment in Europe.

1985

bourse.pngVirbac, the number-two French animal health laboratory, starts to trade on the secondary market of the Paris stock exchange.

1987

allerderm.pngWith the acquisition of Allerderm Inc., Virbac enters the US market, where it specializes in the new veterinary dermatology market and becomes a global leader a few years later.

1988

leucogen.pngWith the first genetically engineered vaccine against feline leukemia made from a purified p45 FeLV-envelope retrovirus, Virbac provides veterinarians with an effective solution against a disease in cats for which there was no cure at the time.

1989

imperial-dog.pngVirbac acquires Imperial Dog, a dog and cat food manufacturer, founded by the creator of Royal Canin, now Virbac Nutrition.

1991

vaccin-renard.pngIn Europe, Virbac offers the first oral anti-rabies vaccine for foxes, obtained by selective mutation.

1992

PRD-JD.pngVeterinarian doctor Pierre-Richard Dick, founder of Virbac, dies suddenly at the age of 55 while on a Central American sea voyage. Pascal Boissy, then financial director, succeeds him to head the company. Six months later, the company adopts a new organizational structure made up of an executive board and a supervisory board, of which Jeanine Dick, wife of the founder, become chairwoman.

1992

asie.pngVirbac continues its international expansion with the creation of its first subsidiary in Asia (a partnership with Maruyasu, a Japanese import-export company).

1996

fusion.pngNumerous companies created to develop the company on French territory merge into a single subsidiary, Virbac France, formalizing the beginning of the Virbac umbrella brand.

1998

jelaime,jelevaccine.pngThrough its “I love my pet, I vaccinate it” poster campaign, Virbac raises the general public’s awareness of vaccination in France.

1999

EM.pngEric Marée, 48 years old, graduate of HEC and holder of an MBA from Cornell University in the United States, becomes chairman of the Virbac executive board.

1999

stlouis.pngThanks to the acquisition of Agri-Nutrition, a company based in St. Louis (Missouri), Virbac acquires a range of dental care and hygiene products.

2001

virbagen-omega.pngVirbac offers veterinarians the first interferon omega for dogs and cats in Europe.

2001

fondation2001.pngThe Pierre-Richard Dick Foundation, created in 1993 after the founder’s death, becomes the Virbac Corporate Foundation. Chaired by his son, Jean-Pierre Dick, it aims to raise public awareness, educate and inform, especially children, about issues related to the integration and well-being of animals in cities.

2001

JPdick.pngVirbac joins Jean-Pierre Dick, son of the founder and doctor of veterinary medicine, on his sailing adventure: through his involvement in epic races, the skipper helps to enhance the veterinary profession and promote animal health.

2006

MHDick.pngMarie-Hélène Dick, daughter of the founder, veterinary doctor and MBA graduate from HEC, is named chairwoman of Virbac’s supervisory board.

2006

inde.pngVirbac becomes number one in India through the acquisition of Agrivet Farm Care, the animal health branch of GlaxoSmithKline.

2008

prod.pngWith 7 production units, Virbac currently has an industrial park on all five continents (France, United States, Mexico, Brazil, Australia, South Africa and Vietnam).

2008

suprelorin.pngVirbac offers veterinarians the first deslorelin-based implant for the induction of temporary infertility in male dogs.

2010

australie.pngVirbac signs an agreement with Pfizer Inc. to acquire the Australian rights to a range of products for food producing animals, primarily parasiticides and vaccines for cattle and sheep.

2011

canileish.pngVirbac launches the first vaccine against canine leishmaniasis in Europe.

2012

aqua.pngVirbac acquires a majority share of Centrovet, animal health market leader in Chile, expert in the development and production of innovative products for the protection and treatment of cold water aquaculture farms (salmon and trout).

2015

cochon.pngVirbac acquires Schweitzer Biotech Company, a Taiwanese company that is an expert in the development of cell culture banks serving as the basis for production of viral vaccines primarily for swine and poultry. This acquisition formalizes the creation of a new biology R&D structure in Southeast Asia, a region recognized for the largest swine and aquaculture (warm water) markets on the planet.

2015

fondation.pngThe Virbac Corporate Foundation, aware of the challenges related to the interconnection between animal, human, and environmental health, initiates support for a screening, control, and prevention program for bovine tuberculosis and rabies in the Gonarezhou Park (Zimbabwe).

2016

argonavis.pngAfter the construction of VB8 in Carros in 2014, a production building dedicated to the manufacture of sterile injectables, Virbac continues to invest in quality and to strengthen its production capacities with Argo Navis, VB8’s alter ego in Mexico.

2017

petfood.pngAfter the physiological range in 2016, Virbac launches a range of dietetic petfood for dogs and cats. Their composition is particularly suited to the dietary needs of carnivores.

2017

voile.pngAt the helm of St. Michel-Virbac, Jean-Pierre Dick wins his fourth Jacques Vabre Race (a first in the history of the Coffee Race). This victory marks a turning point in the life of the sailor and the most fitting closure to his 17 years of adventures around the world, flying Virbac’s colors.

2017

SH.pngSébastien Huron, 47 years old, doctor of veterinary medicine, head of Global Business Operations, and member of the executive board since 2012, succeeds Éric Marée as chairman of Virbac.

2018

50ans332x186px.jpgIn September, Virbac celebrates its 50th anniversary. Along with the family of its founder, nearly 3,000 connected employees share in a two-day event that unfolds in an atmosphere of warmth, intercultural sharing and engagement in the service of animal health

2018

porcelets332x186.jpgVirbac makes a food supplement available in several Asian countries (Taiwan, Vietnam, The Philippines, South Korea and Thailand) to improve the survival of piglets from birth to ten days old. 

2018

smartcap332x186px.jpgVirbac wins a Pharmapack Europe Award for the Smart Cap, a cap for safe extraction of liquid products (also recognized by the ADF Paris Awards in 2019).

2018

lamelles332x186px.jpgVirbac includes in its range of chews the first dental technology that targets both the oral and digestive causes of bad breath (Fr3sh).

2019

Suigen PCV2 vaccin 332x186px.jpgVirbac provides a preventive solution in several Asian countries against porcine circovirus, a virus responsible for significant losses in farms. Developed by the Virbac teams with the genotype predominant in most regions of the world, this vaccine helps limit the impact of this disease in one of the world's most important swine production areas

Legal Notice
Not all medicines and products mentioned on this website are authorised to be marketed in all countries. The product names stated in this document are subject to protection in respect of trademarks. Virbac and/or its subsidiaries are the owners or have exclusive use of them.